Nakanishi (FRA:6SN) 1-Year Sharpe Ratio: 1.21 (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6SN Nakanishi Inc FRA:6SN
93 GF Score
Price €16.50
GF Value €16.85
! 6 Warning Signs
View Full Analysis

What is Nakanishi 1-Year Sharpe Ratio?

Nakanishi FRA:6SN +1.85% 93 1-Year Sharpe Ratio is 1.21 as of Aug. 25, 2026. GuruFocus rates FRA:6SN with a GF Score™ of 93/100 and a GF Value™ of €16.85. The stock has 6 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-25), Nakanishi's 1-Year Sharpe Ratio is 1.21.

Nakanishi  (FRA:6SN) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Nakanishi 1-Year Sharpe Ratio Related Terms

FRA:6SN vs ISRG, BDX, MDLN: 1-Year Sharpe Ratio Comparison

For the Medical Instruments & Supplies subindustry, Nakanishi's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nakanishi 1-Year Sharpe Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nakanishi's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Nakanishi's 1-Year Sharpe Ratio falls into.


FRA:6SN
93GF Score
Nakanishi Inc FRA:6SN
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nakanishi 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 1.21 mean?
Nakanishi (FRA:6SN) has a 1-Year Sharpe Ratio of 1.21 as of Aug. 25, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Nakanishi and its competitors.
Is Nakanishi's 1-Year Sharpe Ratio too high?
Nakanishi's current 1-Year Sharpe Ratio is 1.21. Overall, Nakanishi has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Nakanishi's 1-Year Sharpe Ratio compare to ISRG and BDX?
Nakanishi's 1-Year Sharpe Ratio of 1.21 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Medical Devices & Instruments company?
A good 1-Year Sharpe Ratio depends on the Medical Devices & Instruments industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Nakanishi and its competitors. Nakanishi's current 1-Year Sharpe Ratio is 1.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nakanishi stock overvalued right now?
Nakanishi (FRA:6SN) has a current 1-Year Sharpe Ratio of 1.21. The stock's GF Value™ is €16.85, compared to a current price of €16.50 — trading 2.1% below its estimated fair value. The current 1-Year Sharpe Ratio is 1.21. Nakanishi's overall GF Score™ is 93/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Nakanishi (FRA:6SN), the current 1-Year Sharpe Ratio is 1.21 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nakanishi (FRA:6SN) Overvalued in 2026?

Based on GuruFocus' analysis, Nakanishi stock appears to be undervalued. The current stock price of €16.50 is trading 2.1% below its estimated GF Value™ of €16.85.

Key valuation signals for FRA:6SN:

  • 1-Year Sharpe Ratio: 1.21
  • GF Value™: €16.85 vs. price of €16.50 (2.1% below fair value)
  • GF Score™: 93/100 with 6 warning signs

No single metric tells the full story. See the FRA:6SN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nakanishi Business Description

Other Exchanges NKNSF:USA7716:Japan
Address 700 Shimohinata, Kanuma-shi, Tochigi, JPN
Nakanishi Inc manufactures high-speed rotary cutting technology for the dental industry and the medical industry more broadly. The company distributes its products to countries internationally, earning its key revenue overseas. The company operates via three business segments. The dental product segment manufactures and sells handpieces for dental treatment, mechanical micro motors and handpieces as well as handpieces for surgeries. The surgical business segment manufactures and sells grinders for manual works and spindles for machinery attachment. The Machinery business segment provides inspection and repair services for its dental and medical equipment and general industrial cutting and grinding equipment.
93GF Score

Get the complete analysis for FRA:6SN

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.50
Price
€16.85
GF Value